Pure Global

Sirolimus Eluting Coronary Stent System - India CDSCO Medical Device Registration

Sirolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000042_dd9e936185c45bb38483da5470752fd4_9f60ba44c1640461252c753b0e3c12d7. This device is marketed under the brand name Explorer. The license holder is Dolphin Lifescience India LLP, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Sirolimus Eluting Coronary Stent System
UID: MFG/MD/2019/000042_dd9e936185c45bb38483da5470752fd4_9f60ba44c1640461252c753b0e3c12d7

Brand Name

Explorer

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

The Sirolimus Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease, including patients with acute myocardial infarction (Explorer), due to discrete de novo native coronary artery lesions. The Sirolimus Eluting Coronary Stent System is also intended to be used for treatment of patients presenting with: โ€ข Acute coronary syndrome โ€ข Unstable angina โ€ข Coronary saphenous vein graft lesions โ€ข Coronary artery total occlusion lesions โ€ข In-stent restenosis in coronary artery lesions

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing